Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMuscle aches and generalised body pain do affect some people taking Wegovy, but they are not among the medicine's most common side effects — that distinction belongs to nausea, vomiting and other gut symptoms. Most people who report aches on semaglutide find them mild and short-lived, particularly around dose increases. Wegovy is a prescription-only medicine; a clinician assesses whether it is right for you before any treatment begins, and any new or worsening pain during treatment should be discussed with your prescriber.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A widespread assumption circulates in forums and comment threads: that body aches are an expected, standard side effect of Wegovy, something to push through. That is not quite what the clinical picture shows. The prescribing information for semaglutide lists musculoskeletal pain (covering back pain, joint ache and general myalgia) as an uncommon reported effect rather than a common one. Nausea affects a substantial proportion of people; diffuse body aching affects far fewer.
That does not mean pain reports are fabricated. It means aches on Wegovy are worth thinking about carefully rather than accepted as a given. The timing matters enormously. Discomfort that appears in the first week after a dose increase, then fades, reads very differently from pain that arrives months into stable treatment. So does its character: a dull muscle soreness after you have been walking more (a natural consequence of losing weight and becoming more active) is not the same as sharp or gripping abdominal pain.
The NHS medicines page on semaglutide separates side effects that are common, uncommon and rare, reading it alongside your Patient Information Leaflet gives a much clearer benchmark than online forums. Our clinical team at nume reviews every patient's history before treatment starts, precisely because individual context changes how any symptom should be interpreted.
Several things that happen because of Wegovy's effects can produce aches without being direct drug toxicity. Semaglutide suppresses appetite significantly. If you are eating much less than before, your protein and electrolyte intake may have dropped, and both deficits are known to cause muscle cramps and generalised soreness. Dehydration is also common in early treatment, especially when nausea reduces how much you feel like drinking. Dehydrated muscles ache.
Increased physical activity is another factor. People losing weight often move more, sometimes quite suddenly, and muscles that haven't been used regularly complain about it. That kind of ache tends to cluster around the legs and lower back and to improve with rest and better hydration rather than worsening over time. Leg aches specifically are one of the more frequently searched concerns, and in most cases the explanation sits here rather than in a direct pharmacological effect of semaglutide.
Abdominal cramping or stomach pain, distinct from muscle ache, is a different matter. The gut slows down on GLP-1 treatment and pain in that region can reflect constipation, bloating, or trapped wind. There is a separate and more serious possibility discussed below. Stomach discomfort on Wegovy deserves its own careful assessment, not a blanket reassurance.
In January 2026 the MHRA issued a Drug Safety Update confirming that acute pancreatitis is a known, infrequent but potentially serious risk with GLP-1 receptor agonist medicines including semaglutide. The symptom to watch for is severe abdominal pain that persists and may spread toward the back, sometimes with vomiting. This is not the ordinary stomach discomfort many people experience early in treatment. It is a different quality, intense, unrelenting, not eased by changing position.
If you experience that pattern, stop eating and drinking and get medical help the same day; call 111 or attend A&E if the pain is severe. Do not wait for a scheduled prescriber appointment. The MHRA's Yellow Card scheme allows patients to report serious suspected side effects directly, which contributes to ongoing safety monitoring of these medicines.
Gallbladder problems are a separate concern: semaglutide and rapid weight loss are both associated with gallstone formation, and gallstones can cause episodic, intense right-sided upper abdominal pain radiating to the shoulder. Again, that warrants medical review rather than watchful waiting. A broader look at body aches on Wegovy covers how these presentations differ from one another.
A few things are worth trying before concluding that Wegovy itself is the problem. Check your protein intake, most people on a significant caloric deficit need to be deliberate about hitting at least 1g of protein per kilogram of bodyweight. Prioritise hydration, especially if nausea has been putting you off fluids. Introduce any new activity gradually rather than overhauling your routine in the first week of a dose increase.
If aches are persistent or escalating, contact your prescriber. At nume, aftercare runs seven days a week, if pain flares over a long weekend or during a period when you'd normally defer things (a holiday, a busy patch at work), you don't have to wait until Monday. Your prescriber may want to slow your titration pace, investigate a non-drug cause, or rule out something that needs attention.
Thinking about whether Wegovy is the right treatment for you, or curious about how private Wegovy costs compare before committing? The detail is all there. And if you'd like to understand how Wegovy changes hunger signals rather than just dampening them, that is a different and genuinely interesting aspect of how semaglutide works.
To discuss your own symptom picture, including what body aches on Wegovy can actually mean for your treatment, with a real clinician (not a chatbot, not an automated triage form) speak to our prescribers through a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.